510(k) device
ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip
Phadia AB · Ige, Antigen, Antiserum, Control (DGC, Class II) · First FDA decision Feb 24, 2014, newest Jul 28, 2016Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "ImmunoCAP"
MAUDE reports
1
Brand "ImmunoCAP", since 2015
PubMed studies
1,279
Mentioning "ImmunoCAP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K161899 · Decided Jul 28, 2016 · 17 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
K133404 · Decided Feb 24, 2014 · 110 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ImmunoCAP", any status and sponsor, newest update first.
Abionic SANot on our public-company list
NCT04401631 · 0 participants · Start Nov 2020 · Primary completion Nov 2020
Device: Blood Collection · For: Allergy; Allergic Asthma; Allergy to Cats and 4 more
Sites: Washington D.C., District of Columbia; Baltimore, Maryland; Cincinnati, Ohio
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ImmunoCAP", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code DGC
6 reports: 6 malfunction, 0 injury, 0 death
Newest reports for this brand
- IMMUNOCAPInjury
3004973408-2024-00001 · Received Nov 14, 2024
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Anaphylactoid / Anaphylaxis
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0387-2018 · Started Jul 5, 2017
Reason given: The "Retry" command does not function properly which could cause a shortage of Wash and Rinse solution and affect assay performance and test results.
Cause as FDA categorized it: Device Design · Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Z-0947-2015 · Started Nov 20, 2014 · Posted by FDA Jan 12, 2015
Reason given: During an investigation of instrument logs it was determined that In specific circumstances involving multiple steps, a rack sequencing error may occur. This will result in a mismatch between the sample ID and the test result reported for all subsequent sample racks in that run.
Cause as FDA categorized it: Software design · Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Published research
The most relevant PubMed records for "ImmunoCAP"[tiab]. The summary above synthesizes these.
- NOVEOS and ImmunoCAP Have Similar Performances for Diagnosing Food Allergies.
Trouche-Estival B, Vitte J, Martin-Blondel A, et al. · J Allergy Clin Immunol Pract · 2024Comparative Study
- ImmunoCAP assays: Pros and cons in allergology.
van Hage M, Hamsten C, Valenta R · J Allergy Clin Immunol · 2017Review
- Anaphylaxis to Linum.
León F, Rodríguez M, Cuevas M · Allergol Immunopathol (Madr) · 2003Case Reports, Research Support, Non-U.S. Gov't
- ImmunoCAP ISAC in food allergy diagnosis: a systematic review of diagnostic test accuracy.
Maesa JM, Dobrzynska A, Baños-Álvarez E, et al. · Clin Exp Allergy · 2021Research Support, Non-U.S. Gov't, Systematic Review
- Alpha-Gal-containing biologics and anaphylaxis.
Chinuki Y, Morita E · Allergol Int · 2019Review
- Egg allergy and yellow fever vaccination.
Cançado BLB, Aranda CS, Mallozi MC, et al. · J Pediatr (Rio J) · 2024
- Short-term biological variation of serum tryptase.
Madsen AT, Kristiansen HP, Winther-Larsen A · Clin Chem Lab Med · 2024
- IgE-mediated chlorhexidine allergy-Cross-reactivity with other biguanide disinfectants.
Mueller-Wirth N, Buenter A, Jörg L, et al. · Allergy · 2020Research Support, Non-U.S. Gov't
- A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method.
D'Alessandro M, Bergantini L, Perrone A, et al. · Minerva Med · 2023
- Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study.
van Hage M, Schmid-Grendelmeier P, Skevaki C, et al. · Clin Chem Lab Med · 2017Evaluation Study, Multicenter Study
- Component-resolved diagnosis in adult patients with food-dependent anaphylaxis.
Dubiela P, Dölle-Bierke S, Aurich S, et al. · World Allergy Organ J · 2021
- Sensitization trajectories to multiple allergen components in a population-based birth-cohort.
Farraia M, Mendes FC, Sokhatska O, et al. · Pediatr Allergy Immunol · 2023Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code DGC.
- Quantia IgEBiokit, S.A. · 510(k) 2023
- Kenota 1 Total IgEKenota, Inc. · 510(k) 2024
- Total Immunoglobulin E (IgE)Beckman Coulter, Inc. · 510(k) 2022
- ADVIA Centaur Total IgE (tIgE)Siemens Healthcare Diagnostics, Inc. · 510(k) 2020
- Dimension Vista Ige Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093CKamiya Biomedical Co. · 510(k) 2004
- LacrytestAdiatec SA · 510(k) 2004
- Immunetech Total Ige SystemImmunetech Corporation · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.